CANLI
Yükleniyor Veriler getiriliyor…
/ Atıflar / Detay

Atıf Detayı

Kurum makalesi · Scopus üzerinden alınan atıf kaydı

Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Screening of in vitro antioxidant and enzyme inhibitory activities of different extracts from two uninvestigated wild plants: Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata
European Journal of Integrative Medicine Cilt 8 ss. 286-292
Scopus Toplam 130 atıf DOI
Introduction The importance of plants products in traditional medicine has been recognized for some time. Two plants of Turkish origin, Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata used as traditional Turkish medicine have remained uninvestigated for Alzheimer diseases and diabetes mellitus for their in vitro biological activity despite their use for sleep disorders. The antioxidant and enzyme inhibitory properties of these plants have not been reported. The aim of this study was to determine the total phenolics, flavonoids, and antioxidant as well as their enzyme inhibitory activity (in aqueous and solvent extracts). Methods Antioxidant assays used standard methods to assess phosphomolybdenum, free radical scavenging activity, reducing power, and metal chelating activity on ferrous ions. Additionally, the extracts were tested also for enzyme inhibitory activity (Cholinesterase, Tyrosinase, α-amylase, and α-glucosidase). Results Organic extracts showed the highest anti-cholinesterase (AChE, and BChE) activity, while aqueous extracts showed valuable Tyrosinase inhibitory activity. Total phenolics (expressed as gallic acid equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 46.2 and 25.4 mg in methanolic extracts, 27.5 and 26.2 mg in ethyl acetate extracts, and 37.9 and 46.6 mg in aqueous extracts, respectively. Similarly, total flavonoids (expressed as rutin equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 39.9 and 27.8 mg in methanolic extracts, 17.6 and 52.4 mg in ethyl acetate extracts, and 24.35 and 24.6 mg in aqueous extracts, respectively. Conclusion The reported results may be valuable for preparing new food supplements and can represent a good model for the development of new drug formulations.
Atıf Kaynağı
Atıf Yapan Yayın
HPLC–MS/MS-based metabolic profiling and pharmacological properties of extracts and infusion obtained from Amelanchier parviflora var. dentata
Industrial Crops and Products Cilt 124 ss. 699-706
Scopus Havuzumuzda 17 atıf almış
Amelanchier parviflora var. dentata is an endemic medicinal plant traditionally consumed to treat stomach pain, cardiovascular diseases, and urinary tract infections in Turkey's folk medicine. Although Amelanchier genus is an excellent source of phytochemicals with a panoply of biological activities, no report has been made available on Amelanchier parviflora var. dentata. Thus, the metabolic profiles of methanol, ethyl acetate, and water extracts were obtained using HPLC–MS/MS. Besides, the pharmacological properties such as antioxidant activity and enzyme inhibition effects against acetyl/butyrylcholinesterase, tyrosinase, α-amylase, and α-glucosidase were evaluated. In total, 62, 38, and 16 metabolites were identified from the methanolic, water, and ethyl acetate extracts, respectively. The identified metabolites belong to anthocyanins, phenolic acids, and flavonoids. The tested extracts exhibited different enzyme inhibitory activity against cholinesterases (acetylcholinesterase: 0.52–2.47 mg GEs/g extract and butyrylcholinesterase: 0.47–3.59 mg GEs/g extract), tyrosinase (19.0–145.54 mg KAEs/g extract), α-amylase (0.23–1.10 mmol ACEs/g extract), and α-glucosidase (8.89–9.92 mmol ACEs/ g extract). Evidence from the present study supports the necessity for more research in an endeavor to discover biologically active secondary metabolites from A. parviflora to manage specific ailments.
Atıf Yapan Makale Bilgileri
Kurumlar (8)
İzmir Kâtip Çelebi Üniversitesi Izmir, Turkey
Marmara Üniversitesi Istanbul, Turkey
Pavol Jozef Šafárik University in Košice Kosice, Slovakia
REEF Environmental Consultancy Puducherry, India
Research Center for Pharmaceutical Nanotechnology Tabriz, Iran
Selçuk Üniversitesi Selçuklu, Turkey
University of Mauritius Reduit, Mauritius
University of Nyíregyháza Nyíregyháza, Hungary